Navigation Links
Global Central Nervous System Drugs Market 2011-2015

NEW YORK, July 23, 2012 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Global Central Nervous System Drugs Market 2011-2015

TechNavio's analysts forecast the Global Central Nervous System Drugs market to grow at a CAGR of -3.2 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing size of aging population. The Global EEG/EMG Equipment market has also been witnessing the trend of novel molecules, launched to treat central nervous system disorders effectively. However, patent expiration of key drugs could pose a challenge to the growth of this market.

TechNavio's report, the Global Central Nervous System Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Central Nervous System Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include AstraZeneca plc, Eli Lilly & Co., Johnson & Johnson Ltd., and Pfizer Inc. Other vendors mentioned in the report: Abbott Laboratories, Sanofi S.A., Bristol-Myers Squibb Co., Eisai Co. Ltd., UCB Pharma, Merck & Co. Inc., Schering-Plough Corp., Shire plc, and Cephalon Inc.

Key questions answered in this report:

What will the market size be in 2015 and at what rate will it grow? What key trends is this market subject to? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the opportunities and threats faced by each of these key vendors? What are the strengths and weaknesses of each of these key vendors? You can request one free hour of analyst time when you purchase this report. Details provided within the report.01. Executive Summary 02. Introduction 03. Market Coverage Overview Product Offerings 04. Market Landscape Global Central Nervous System Drugs Market Market Size Key Market Segments 04.1 Global Antipsychotics Market 04.2 Global Antidepressants Market 04.3 Global Antiepileptic Drugs Market 04.4 Global Anti-Alzheimer's Drugs Market 04.5 Global ADHD Drugs Market 04.6 Global Hypnotics Market 04.7 Global Anti-Parkinson's Drugs Market 04.8 Global Antimigraine Drugs Market Segmentation of Global Central Nervous System Drugs Market Five Forces Analysis 05. Geographical Segmentation 06. Key Leading Countries USA Japan Germany 07. Rate of Incidence and Prevalence 08. Vendor Landscape Matrix of the Product Portfolio Matrix Vendor Landscape of the Leading CNS Drugs Market Segments 08.1 Global Antipsychotics Market Segment 08.2 Global Antidepressants Market Segment 08.3 Global Antiepileptic Drugs Market Segment 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 15.1 Eli Lilly and Co. Business Overview SWOT Analysis 15.2 Pfizer Inc. Business Overview SWOT Analysis 15.3 AstraZeneca plc Business Overview SWOT Analysis 15.4 Johnson and Johnson Ltd. Business Overview SWOT Analysis 16. Other Reports in this Series

List of Exhibits:

Exhibit 1: Global Central Nervous System Drugs Market 2011-2015 (US$ billion)

Exhibit 2: Global Central Nervous System Drugs Market Segmentation 2011

Exhibit 3: Global Central Nervous System Drugs Market by Product Segmentation 2011-2015 (percent)

Exhibit 4: Global Antipsychotics Market 2011-2015 (US$ billion)

Exhibit 5: Global Antidepressants Market 2011-2015 (US$ billion)

Exhibit 6: Global Antiepileptic Drugs Market 2011-2015 (US$ billion)

Exhibit 7: Global Anti-Alzheimer's Drugs Market 2011-2015 (US$ billion)

Exhibit 8: Global Attention Deficit Hyperactivity Disorder Drugs Market 2011-2015 (US$ billion)

Exhibit 9: Global Hypnotics Market 2011-2015 (US$ billion)

Exhibit 10: Global Anti-Parkinson's Drugs Market 2011-2015 (US$ billion)

Exhibit 11: Global Antimigraine Drugs Market 2011-2015 (US$ billion)

Exhibit 12: Global Central Nervous System Market by Overall Market Segmentation (US$ billion)

Exhibit 13: Global Central Nervous System Drugs Market by Geographical Segmentation 2011

Exhibit 14: Global Central Nervous System Drugs Market by Vendor Segmentation 2011

Exhibit 15: Global Antipsychotics Market by Vendor Segmentation 2011

Exhibit 16: Global Antidepressants Market by Vendor Segmentation 2011

Exhibit 17: Global Antiepileptic Drugs Market by Vendor Segmentation 2011

To order this report:Drug and Medication Industry: Global Central Nervous System Drugs Market 2011-2015

More Market Research Report

Check our Industry Analysis and Insights

Nicolas Bombourg
US: (805)652-2626
Intl: +1 805-652-2626


SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sysmex and Siemens Renew Global Partnership for Hemostasis Solutions and Services
2. China Health Resource Announces Go Global Initiative For New Product Introductions
3. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
4. Medica Announces Global Release of the EasyCell Assistant Analyzer for Hematology Laboratories
5. Enteral Feeding Devices Industry is Expected to Reach USD 2,447.6 Million Globally in 2018: Transparency Market Research
6. Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
7. Global Medical Device Industry 2012-2017: Trend, Profit, and Forecast Analysis
8. Global Cardiovascular Device Industry 2012-2017: Trend, Profit and Forecast Analysis
9. Science Translational Medicine and the DMM Global Foundation Announce Days of Molecular Medicine 2012 "The Translational Science of Rare Diseases: From Rare To Care."
10. 2012 Global APTT Market Outlook: Test Volume Forecasts by Country and Market Segment
11. Global Bio-Clinical Trials 2012 Just Launched in India!
Post Your Comments:
(Date:11/25/2015)... -- Henry Schein, Inc., the world,s largest provider of health ... animal health practitioners, will unveil at the Greater New ... Pavilion , which brings together for the first time ... help any practice or laboratory enter the digital age. ... of experts appearing at the Pavilion. --> ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ), a ... start-up  biotechnology company focused on the development of ... by the F-Prime Biomedical Research Initiative (FBRI), today ... collaboration to support the discovery and development of ... Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ ... "Company") (NYSE: MR ), a ... medical devices worldwide, today announced that ... general meeting of shareholders at the ... Grand Century, 193 Prince Edward West Road, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of ... patients are aware of the benefits of Botox® in the treatment of moderate facial ... discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a ... sleep tracking systems. The new app features a more intuitive SleepScore™ that rates sleep ... well you slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the ...
(Date:11/25/2015)... MI (PRWEB) , ... November 25, 2015 , ... In ... Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy ... medical and surgical intensive care units (totaling 30 beds) from May 2014 through October ...
(Date:11/25/2015)... ... , ... Today, Mothers Against Drunk Driving (MADD) learned that the ... the first time since 2011. In 2014, there were 9,967 fatalities involving an alcohol ... National Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):